Intranasal bevacizumab injections improve quality of life in HHT patients.

MLA

Steineger, Johan, et al. “Intranasal Bevacizumab Injections Improve Quality of Life in HHT Patients.” Laryngoscope, vol. 130, no. 5, May 2020, pp. E284–88. EBSCOhost, https://doi.org/10.1002/lary.28179.

APA

Steineger, J., Geirdal, A. Ø., Osnes, T., Heimdal, K. R., & Dheyauldeen, S. (2020). Intranasal bevacizumab injections improve quality of life in HHT patients. Laryngoscope, 130(5), E284–E288. https://doi.org/10.1002/lary.28179

Chicago

Steineger, Johan, Amy Østerhus Geirdal, Terje Osnes, Ketil Riddervold Heimdal, and Sinan Dheyauldeen. 2020. “Intranasal Bevacizumab Injections Improve Quality of Life in HHT Patients.” Laryngoscope 130 (5): E284–88. doi:10.1002/lary.28179.